Concepedia

Russell C. Petter

RC

45

Publications

3.6K

Citations

27

H-Index

1984

Active since

Affiliations

Biogen (United States)(Current)

University of Pittsburgh

Clovis Oncology (United States)

University of California, Los Angeles

Russell C. Petter is an author at Biogen (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1984–2016

45

Publications

45

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 622 citations · Full text

Cooperative binding by aggregated mono-6-(alkylamino)-.beta.-cyclodextrins

Russell C. Petter, Jeffrey S. Salek, Christopher T. Sikorski et al. · Journal of the American Chemical Society · 1990 · 465 citations

, , +11

Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans

Erica N Evans, Richland Tester, Sharon Aslanian et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 219 citations

Catalytic hydrolysis of a phosphate triester by tetracoordinated zinc complexes

Samuel H. Gellman, Russell C. Petter, Ronald Breslow · Journal of the American Chemical Society · 1986 · 219 citations

, , +12

Targeted covalent drugs of the kinase family

Juswinder Singh, Russell C. Petter, Arthur F. Kluge · Current Opinion in Chemical Biology · 2010 · 175 citations

, , +5

Rows per page

1–5 of 45